HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 67 filers reported holding HARVARD BIOSCIENCE INC in Q1 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $117 | -63.3% | 27,854 | -75.8% | 0.01% | -70.0% |
| Q4 2022 | $319 | -99.8% | 115,330 | +48.2% | 0.04% | +53.8% |
| Q3 2022 | $199,000 | -19.8% | 77,816 | +34.4% | 0.03% | -36.6% |
| Q4 2020 | $248,000 | +73.4% | 57,880 | +21.7% | 0.04% | +70.8% |
| Q3 2020 | $143,000 | +191.8% | 47,576 | +197.4% | 0.02% | +300.0% |
| Q4 2019 | $49,000 | -3.9% | 15,995 | -3.0% | 0.01% | -14.3% |
| Q3 2019 | $51,000 | -50.5% | 16,495 | -68.0% | 0.01% | -41.7% |
| Q2 2019 | $103,000 | -86.7% | 51,495 | -71.4% | 0.01% | -84.8% |
| Q1 2019 | $776,000 | +27.4% | 180,157 | -6.0% | 0.08% | +12.9% |
| Q4 2018 | $609,000 | -36.3% | 191,657 | +5.3% | 0.07% | +32.1% |
| Q3 2018 | $956,000 | +1.9% | 182,057 | +3.8% | 0.05% | +12.8% |
| Q2 2018 | $938,000 | +5.7% | 175,357 | -1.1% | 0.05% | 0.0% |
| Q1 2018 | $887,000 | +37.3% | 177,357 | -9.4% | 0.05% | +20.5% |
| Q4 2017 | $646,000 | -18.8% | 195,857 | -7.8% | 0.04% | -27.8% |
| Q3 2017 | $796,000 | +35.6% | 212,317 | -7.7% | 0.05% | +42.1% |
| Q2 2017 | $587,000 | -1.8% | 230,019 | 0.0% | 0.04% | +18.8% |
| Q1 2017 | $598,000 | -25.2% | 230,019 | -12.3% | 0.03% | -33.3% |
| Q4 2016 | $800,000 | +5.0% | 262,398 | -6.3% | 0.05% | +17.1% |
| Q3 2016 | $762,000 | -7.2% | 280,031 | -2.4% | 0.04% | -8.9% |
| Q2 2016 | $821,000 | -25.3% | 287,031 | -21.2% | 0.04% | -35.7% |
| Q1 2016 | $1,099,000 | -31.4% | 364,055 | -21.1% | 0.07% | -10.3% |
| Q4 2015 | $1,601,000 | -25.9% | 461,427 | -19.3% | 0.08% | -26.4% |
| Q3 2015 | $2,161,000 | -23.1% | 571,673 | +16.0% | 0.11% | -1.9% |
| Q2 2015 | $2,809,000 | +63.6% | 492,884 | +67.0% | 0.11% | +58.8% |
| Q1 2015 | $1,717,000 | +42.8% | 295,072 | +39.2% | 0.07% | -19.0% |
| Q4 2014 | $1,202,000 | +22.4% | 212,031 | -11.7% | 0.08% | +61.5% |
| Q3 2014 | $982,000 | -4.2% | 240,169 | +6.7% | 0.05% | +13.0% |
| Q2 2014 | $1,025,000 | +91.6% | 225,193 | +99.6% | 0.05% | +21.1% |
| Q1 2014 | $535,000 | +24.1% | 112,810 | +22.9% | 0.04% | +11.8% |
| Q4 2013 | $431,000 | +20.1% | 91,766 | +34.5% | 0.03% | +21.4% |
| Q3 2013 | $359,000 | -49.9% | 68,237 | -55.2% | 0.03% | -67.1% |
| Q2 2013 | $716,000 | – | 152,295 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
| Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
| Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
| Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
| Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
| Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
| BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
| GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
| Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |